{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:08:35Z","timestamp":1761577715106,"version":"build-2065373602"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007237","name":"University of North Dakota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.meegid.2021.104710","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T20:11:22Z","timestamp":1610223082000},"page":"104710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48\/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development"],"prefix":"10.1016","volume":"89","author":[{"given":"Soheila","family":"Asali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbasali","family":"Raz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibollah","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladan","family":"Mafakher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Razmjou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Solaymani-Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2021.104710_bb0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.parint.2019.03.001","article-title":"Polymorphisms in genes associated with drug resistance of Plasmodium vivax in India","volume":"70","author":"Anantabotla","year":"2019","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.meegid.2021.104710_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/imr.12816","article-title":"The immunology of Plasmodium vivax malaria","volume":"293","author":"Antonelli","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2021.104710_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4269\/ajtmh.2005.73.5_suppl.0730038","article-title":"Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia","volume":"73","author":"Arevalo-Herrera","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2021.104710_bb0020","doi-asserted-by":"crossref","first-page":"e0119335","DOI":"10.1371\/journal.pone.0119335","article-title":"Recombinant Pvs48\/45 antigen expressed in E. coli generates antibodies that block malaria transmission in Anopheles albimanus mosquitoes","volume":"10","author":"Arevalo-Herrera","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 2","key":"10.1016\/j.meegid.2021.104710_bb0025","first-page":"15","article-title":"Molecular epidemiology of malaria in endemic areas of Iran","volume":"34","author":"Assmar","year":"2003","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"10.1016\/j.meegid.2021.104710_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-1119(00)00478-9","article-title":"Genetic variation and the recent worldwide expansion of Plasmodium falciparum","volume":"261","author":"Ayala","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.meegid.2021.104710_bb0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.micinf.2016.06.009","article-title":"Adaptive immune response in symptomatic and asymptomatic enteric protozoal infection: evidence for a determining role of parasite genetic heterogeneity in host immunity to human giardiasis","volume":"18","author":"Babaei","year":"2016","journal-title":"Microbes Infect."},{"key":"10.1016\/j.meegid.2021.104710_bb0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/CMR.00074-12","article-title":"Evidence and implications of mortality associated with acute Plasmodium vivax malaria","volume":"26","author":"Baird","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.meegid.2021.104710_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbiopara.2010.03.019","article-title":"Malaria gametocytogenesis","volume":"172","author":"Baker","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.actatropica.2017.02.032","article-title":"Antibodies elicited during natural infection in a predominantly Plasmodium falciparum transmission area cross-react with sexual stage-specific antigen in P. vivax","volume":"170","author":"Bansal","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.meegid.2021.104710_bb0055","first-page":"789","article-title":"Spatial outline of malaria transmission in Iran. Asian Pac","volume":"5","author":"Barati","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.meegid.2021.104710_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fimmu.2014.00359","article-title":"Strategies for designing and monitoring malaria vaccines targeting diverse antigens","volume":"5","author":"Barry","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2021.104710_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008497","article-title":"Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum","volume":"4","author":"Barry","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104710_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.ento.43.1.519","article-title":"Malaria parasite development in mosquitoes","volume":"43","author":"Beier","year":"1998","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.meegid.2021.104710_bb0075","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1038\/s41598-017-06130-1","article-title":"Evaluation of two lead malaria transmission blocking vaccine candidate antibodies in natural parasite-vector combinations","volume":"7","author":"Bompard","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.meegid.2021.104710_bb0080","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3389\/fimmu.2018.02780","article-title":"Combination of RTS,S and Pfs25-IMX313 induces a functional antibody response against malaria infection and transmission in mice","volume":"9","author":"Brod","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2021.104710_bb0085","doi-asserted-by":"crossref","first-page":"W402","DOI":"10.1093\/nar\/gkz297","article-title":"The PSIPRED protein analysis workbench: 20 years on","volume":"47","author":"Buchan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.104710_bb0090","doi-asserted-by":"crossref","first-page":"e0158212","DOI":"10.1371\/journal.pone.0158212","article-title":"Immunological cross-reactivity between malaria vaccine target antigen P48\/45 in Plasmodium vivax and P. falciparum and cross-boosting of immune responses","volume":"11","author":"Cao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104710_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01627-18","article-title":"Functional conservation of P48\/45 proteins in the transmission stages of Plasmodium vivax (human malaria parasite) and P. berghei (murine malaria parasite)","volume":"9","author":"Cao","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.meegid.2021.104710_bb0100","first-page":"457","article-title":"The crystal structure of C-terminal merozoite surface protein 1 at 1.8 a resolution, a highly protective malaria vaccine candidate. Mol","volume":"3","author":"Chitarra","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.meegid.2021.104710_bb0105","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijpara.2012.09.002","article-title":"Measuring the blockade of malaria transmission--an analysis of the standard membrane feeding assay","volume":"42","author":"Churcher","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0110","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1016\/j.vaccine.2011.04.028","article-title":"Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax","volume":"29","author":"Doi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.104710_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pt.2015.04.010","article-title":"Active migration and passive transport of malaria parasites","volume":"31","author":"Douglas","year":"2015","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.meegid.2021.104710_bb0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s13071-015-1232-4","article-title":"Genetic diversity of transmission-blocking vaccine candidate Pvs48\/45 in Plasmodium vivax populations in China","volume":"8","author":"Feng","year":"2015","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.meegid.2021.104710_bb0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the Plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104710_bb0135","doi-asserted-by":"crossref","first-page":"a025478","DOI":"10.1101\/cshperspect.a025478","article-title":"Plasmodium sporozoite biology","volume":"7","author":"Frischknecht","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.meegid.2021.104710_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1475-2875-6-154","article-title":"Sequence diversity and natural selection at domain I of the apical membrane antigen 1 among Indian Plasmodium falciparum populations","volume":"6","author":"Garg","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0145","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.meegid.2010.12.002","article-title":"Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates","volume":"11","author":"Garzon-Ospina","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2021.104710_bb0150","first-page":"681","article-title":"SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"CABIOS"},{"key":"10.1016\/j.meegid.2021.104710_bb6000","doi-asserted-by":"crossref","unstructured":"Ghayour Najafabadi, Z., Oormazdi, H., Akhlaghi, L., Meamar, A.R., Nateghpour, M., Farivar, L., Razmjou, E., 2014a. Detection of Plasmodium vivax and Plasmodium falciparum DNA in human saliva and urine: loop-mediated isothermal amplification for malaria diagnosis. Acta Trop. 136, 44\u200e\u2013\u200e49.","DOI":"10.1016\/j.actatropica.2014.03.029"},{"key":"10.1016\/j.meegid.2021.104710_bb0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/trstmh\/tru061","article-title":"Mitochondrial PCR-based malaria detection in saliva and urine of symptomatic patients","volume":"108","author":"Ghayour Najafabadi","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2021.104710_bb0160","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1073\/pnas.94.13.6786","article-title":"Continuous in vitro propagation of the malaria parasite Plasmodium vivax","volume":"94","author":"Golenda","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2021.104710_bb0165","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1365-3156.2008.02166.x","article-title":"Modelling of malaria temporal variations in Iran","volume":"13","author":"Haghdoost","year":"2008","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.meegid.2021.104710_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actatropica.2012.01.003","article-title":"Spatial analysis and mapping of malaria risk in an endemic area, south of Iran: a GIS based decision making for planning of control","volume":"122","author":"Hanafi-Bojd","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.meegid.2021.104710_bb0175","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1475-2875-9-254","article-title":"A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting","volume":"9","author":"Harris","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0180","first-page":"172","article-title":"Asymptomatic malaria and its challenges in the malaria elimination program in Iran: a systematic review","volume":"11","author":"Hassanpour","year":"2017","journal-title":"J. Arthropod. Borne Dis."},{"key":"10.1016\/j.meegid.2021.104710_bb0185","first-page":"88","article-title":"Malaria elimination in Iran, importance and challenges","volume":"4","author":"Hemami","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.meegid.2021.104710_bb0190","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1128\/IAI.68.12.6618-6623.2000","article-title":"Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes","volume":"68","author":"Hisaeda","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2021.104710_bb0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0264-410X(01)00402-9","article-title":"Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism","volume":"20","author":"Hisaeda","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.104710_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","article-title":"Global epidemiology of Plasmodium vivax","volume":"95","author":"Howes","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.meegid.2021.104710_bb0205","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imr.12828","article-title":"Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites","volume":"293","author":"de Jong","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2021.104710_bb0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-12-144","article-title":"Limited sequence polymorphisms of four transmission-blocking vaccine candidate antigens in Plasmodium vivax Korean isolates","volume":"12","author":"Kang","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0952-7915(93)90037-S","article-title":"Transmission-blocking immunity against malaria and other vector-borne diseases","volume":"5","author":"Kaslow","year":"1993","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.meegid.2021.104710_bb0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/333074a0","article-title":"A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains","volume":"333","author":"Kaslow","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104710_bb0225","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1126\/science.1925544","article-title":"Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus","volume":"252","author":"Kaslow","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.meegid.2021.104710_bb0230","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0167-7799(92)90280-9","article-title":"Malaria transmission-blocking vaccines","volume":"10","author":"Kaslow","year":"1992","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.meegid.2021.104710_bb0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12936-019-3009-2","article-title":"The persistence of naturally acquired antibodies and memory B cells specific to rhoptry proteins of Plasmodium vivax in patients from areas of low malaria transmission","volume":"18","author":"Kochayoo","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-6851(93)90158-T","article-title":"Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48\/45 of Plasmodium falciparum","volume":"61","author":"Kocken","year":"1993","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0245","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.meegid.2021.104710_bb0250","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0020-7519(02)00184-4","article-title":"Functional characterisation of sexual stage specific proteins in Plasmodium falciparum","volume":"32","author":"Kongkasuriyachai","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0255","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1101\/gr.2523904","article-title":"Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle","volume":"14","author":"Le Roch","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.meegid.2021.104710_bb0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/jmbi.1997.1038","article-title":"Regulation and trafficking of three distinct 18 S ribosomal RNAs during development of the malaria parasite","volume":"269","author":"Li","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2021.104710_bb0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.exppara.2012.08.010","article-title":"Plasmodium vivax: reverse transcriptase real-time PCR for gametocyte detection and quantitation in clinical samples","volume":"132","author":"Lima","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0270","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/eri.13.45","article-title":"The silent threat: asymptomatic parasitemia and malaria transmission","volume":"11","author":"Lindblade","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.meegid.2021.104710_bb0275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.11.010","article-title":"Plasmodium falciparum","volume":"35","author":"Maier","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0280","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria","volume":"23","author":"Malkin","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.104710_bb0285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fcimb.2019.00135","article-title":"A multi-stage Plasmodium vivax malaria vaccine candidate able to induce long-lived antibody responses against blood stage parasites and robust transmission-blocking activity","volume":"9","author":"McCaffery","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.meegid.2021.104710_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.parepi.2016.06.001","article-title":"The relation between climatic factors and malaria incidence in Kerman, South East of Iran","volume":"1","author":"Mohammadkhani","year":"2016","journal-title":"Parasite Epidemiol. Control"},{"key":"10.1016\/j.meegid.2021.104710_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s12879-016-1857-8","article-title":"Molecular evidence of high rates of asymptomatic P. vivax infection and very low P. falciparum malaria in Botswana","volume":"16","author":"Motshoge","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104710_bb0300","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","article-title":"Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite","volume":"9","author":"Mueller","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104710_bb0305","doi-asserted-by":"crossref","first-page":"e02116","DOI":"10.1128\/AAC.02116-18","article-title":"Emergence of Plasmodium vivax resistance to chloroquine in French Guiana","volume":"63","author":"Musset","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104710_bb0310","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/IAI.01147-07","article-title":"Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa","volume":"76","author":"Nebie","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.meegid.2021.104710_bb0315","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.apjtm.2016.09.007","article-title":"Epidemiological status of malaria in Iran, 2011-2014","volume":"9","author":"Norouzinejad","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.meegid.2021.104710_bb0320","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pt.2013.03.012","article-title":"1912-2012: a century of research on Plasmodium vivax in vitro culture","volume":"29","author":"Noulin","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112496","article-title":"Hematopoietic stem\/progenitor cell sources to generate reticulocytes for Plasmodium vivax culture","volume":"9","author":"Noulin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104710_bb0330","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00582-18","article-title":"Reversal of chloroquine resistance of Plasmodium vivax in aotus monkeys","volume":"62","author":"Obaldia","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2021.104710_bb0335","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ijpara.2007.05.009","article-title":"Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax","volume":"37","author":"Panichakul","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0340","first-page":"1","article-title":"From a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivax","author":"Patarroyo","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.meegid.2021.104710_bb0345","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/426398","article-title":"Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village","volume":"191","author":"Perraut","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104710_bb0350","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1086\/599041","article-title":"Vivax malaria: a major cause of morbidity in early infancy","volume":"48","author":"Poespoprodjo","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2021.104710_bb0355","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2015002","article-title":"Major infectious diseases affecting the afghan immigrant population of Iran: a systematic review and meta-analysis","volume":"37","author":"Pourhossein","year":"2015","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.meegid.2021.104710_bb0360","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(07)60160-3","article-title":"Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison","volume":"369","author":"Ratcliff","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2021.104710_bb0365","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.4161\/hv.26157","article-title":"Plasmodium vivax malaria vaccines: why are we where we are?","volume":"9","author":"Reyes-Sandoval","year":"2013","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.meegid.2021.104710_bb0370","first-page":"1004","article-title":"Challenges and the path forward on malaria elimination intervention: a systematic review. Iran. J","volume":"48","author":"Shahandeh","year":"2019","journal-title":"Public Health"},{"key":"10.1016\/j.meegid.2021.104710_bb0375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12936-017-1782-3","article-title":"A novel model fitted to multiple life stages of malaria for assessing efficacy of transmission-blocking interventions","volume":"16","author":"Sherrard-Smith","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0380","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12936-018-2411-5","article-title":"Chloroquine resistance is associated to multi-copy pvcrt-o gene in Plasmodium vivax malaria in the Brazilian Amazon","volume":"17","author":"Silva","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0385","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gki408","article-title":"The HHpred interactive server for protein homology detection and structure prediction","volume":"33","author":"S\u00f6ding","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.104710_bb0390","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.1100606","article-title":"Host immunity and pathogen strain contribute to intestinal disaccharidase impairment following gut infection","volume":"187","author":"Solaymani-Mohammadi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2021.104710_bb0395","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/mi.2012.80","article-title":"Regulation of intestinal epithelial cell cytoskeletal remodeling by cellular immunity following gut infection","volume":"6","author":"Solaymani-Mohammadi","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.meegid.2021.104710_bb0400","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.vaccine.2012.01.003","article-title":"Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate","volume":"30","author":"Tachibana","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.104710_bb0405","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.vaccine.2015.03.008","article-title":"Plasmodium vivax gametocyte proteins, Pvs48\/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization","volume":"33","author":"Tachibana","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2021.104710_bb0410","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/genetics\/123.1.229","article-title":"DNA polymorphism in a subdivided population: the expected number of segregating sites in the two-subpopulation model","volume":"123","author":"Tajima","year":"1989","journal-title":"Genetics"},{"key":"10.1016\/j.meegid.2021.104710_bb0415","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/genetics\/123.3.585","article-title":"Statistical method for testing the neutral mutation hypothesis by DNA polymorphism","volume":"123","author":"Tajima","year":"1989","journal-title":"Genetics"},{"key":"10.1016\/j.meegid.2021.104710_bb0420","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","article-title":"Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'","volume":"31","author":"Takala","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.meegid.2021.104710_bb0425","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pt.2016.07.003","article-title":"Functional antibodies and protection against blood-stage malaria","volume":"32","author":"Teo","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpara.2016.09.006","article-title":"Plasmodium vivax vaccine research - we've only just begun","volume":"47","author":"Tham","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0435","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF03401770","article-title":"Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates","volume":"4","author":"Tsuboi","year":"1998","journal-title":"Mol. Med."},{"key":"10.1016\/j.meegid.2021.104710_bb0440","first-page":"36","article-title":"Absence of asymptomatic malaria infection in endemic area of Bashagard District, Hormozgan Province, Iran","volume":"7","author":"Turki","year":"2012","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0445","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12936-016-1263-0","article-title":"Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48\/45","volume":"15","author":"Vallejo","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016257","article-title":"Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study","volume":"6","author":"Van den Eede","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104710_bb0455","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12936-019-2836-5","article-title":"Malaria situation in Iran: 2002-2017","volume":"18","author":"Vatandoost","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.meegid.2021.104710_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007470","article-title":"Plasmodium knowlesi as a model system for characterising Plasmodium vivax drug resistance candidate genes","volume":"13","author":"Verzier","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.meegid.2021.104710_bb0465","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng1930","article-title":"A genome-wide map of diversity in Plasmodium falciparum","volume":"39","author":"Volkman","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.meegid.2021.104710_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076316","article-title":"Strategies for detection of Plasmodium species gametocytes","volume":"8","author":"Wampfler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2021.104710_bb0475","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/jcm.26.5.923-927.1988","article-title":"Characterization of antibodies to sporozoites in Plasmodium falciparum malaria and correlation with protection","volume":"26","author":"Webster","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2021.104710_bb0480","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2021.104710_bb0485","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0166-6851(93)90058-6","article-title":"Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230","volume":"58","author":"Williamson","year":"1993","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.meegid.2021.104710_bb0490","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1590\/S0074-02762013000300015","article-title":"Sequence polymorphisms in Pvs48\/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea","volume":"108","author":"Woo","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.meegid.2021.104710_bb0495","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature00813","article-title":"Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum","volume":"418","author":"Wootton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2021.104710_bb0500","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.actatropica.2008.09.012","article-title":"Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran","volume":"109","author":"Zakeri","year":"2009","journal-title":"Acta Trop."},{"key":"10.1016\/j.meegid.2021.104710_bb0505","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinforma."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134821000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T14:44:13Z","timestamp":1761576253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134821000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":102,"alternative-id":["S1567134821000071"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104710","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restricted genetic heterogeneity of the Plasmodium vivax transmission-blocking vaccine (TBV) candidate Pvs48\/45 in a low transmission setting: Implications for the Plasmodium vivax malaria vaccine development","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2021.104710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104710"}}